173 related articles for article (PubMed ID: 33098692)
1. Integrating neuronal involvement into the immune and genetic paradigm of vitiligo.
Al Abadie MS; Gawkrodger DJ
Clin Exp Dermatol; 2021 Jun; 46(4):646-650. PubMed ID: 33098692
[TBL] [Abstract][Full Text] [Related]
2. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
Front Immunol; 2020; 11():579022. PubMed ID: 33240267
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo: pathogenetic hypotheses and targets for current therapies.
Guerra L; Dellambra E; Brescia S; Raskovic D
Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
[TBL] [Abstract][Full Text] [Related]
4. Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments.
Lotti T; Zanardelli M; D'Erme AM
Wien Med Wochenschr; 2014 Jul; 164(13-14):278-85. PubMed ID: 25059737
[TBL] [Abstract][Full Text] [Related]
5. The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature.
Relke N; Gooderham M
J Cutan Med Surg; 2019; 23(3):298-306. PubMed ID: 30902022
[TBL] [Abstract][Full Text] [Related]
6. New insights into immune mechanisms of vitiligo.
Boniface K; Taïeb A; Seneschal J
G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
Boniface K; Seneschal J; Picardo M; Taïeb A
Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata.
Barbulescu CC; Goldstein NB; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2020 Jan; 140(1):29-37. PubMed ID: 31196751
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Different Genes Expressions during Immunological and Inflammatory Responses in Vitiligo.
Sharma CK; Sharma M; Prasad K
Crit Rev Eukaryot Gene Expr; 2017; 27(3):277-287. PubMed ID: 29199612
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune melanocyte destruction in vitiligo.
van den Wijngaard R; Wankowicz-Kalinska A; Pals S; Weening J; Das P
Lab Invest; 2001 Aug; 81(8):1061-7. PubMed ID: 11502857
[No Abstract] [Full Text] [Related]
11. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
Wang Y; Li S; Li C
Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
[TBL] [Abstract][Full Text] [Related]
12. The role of tumor necrosis factor-α in the pathogenesis of vitiligo.
Camara-Lemarroy CR; Salas-Alanis JC
Am J Clin Dermatol; 2013 Oct; 14(5):343-50. PubMed ID: 23912226
[TBL] [Abstract][Full Text] [Related]
13. Neuro-immuno-endocrine processes in vitiligo pathogenesis.
Miniati A; Weng Z; Zhang B; Stratigos AJ; Nicolaidou E; Theoharides TC
Int J Immunopathol Pharmacol; 2012; 25(1):1-7. PubMed ID: 22507311
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.
Craiglow BG; King BA
JAMA Dermatol; 2015 Oct; 151(10):1110-2. PubMed ID: 26107994
[TBL] [Abstract][Full Text] [Related]
16. Jak Inhibitors Reverse Vitiligo in Mice but Do Not Deplete Skin Resident Memory T Cells.
Azzolino V; Zapata L; Garg M; Gjoni M; Riding RL; Strassner JP; Richmond JM; Harris JE
J Invest Dermatol; 2021 Jan; 141(1):182-184.e1. PubMed ID: 32464150
[No Abstract] [Full Text] [Related]
17. Innate immune mechanisms in vitiligo: danger from within.
Richmond JM; Frisoli ML; Harris JE
Curr Opin Immunol; 2013 Dec; 25(6):676-82. PubMed ID: 24238922
[TBL] [Abstract][Full Text] [Related]
18. Cytokines: the yin and yang of vitiligo pathogenesis.
Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
[TBL] [Abstract][Full Text] [Related]
20. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
